Officinae Bio, Part Of Maravai Lifesciences

Officinae Bio, Part Of Maravai Lifesciences company information, Employees & Contact Information

At Officinae Bio we're developing a platform to support the future of biologically designed therapeutics. By developing breakthroughs in AI-enabled methodologies for nucleic manufacture we’re supporting pioneering research in Gene-modified Cell therapy, Gene therapy and RNA therapeutic research. DNA platform An automated platform for streamlined development of plasmids and libraries for viral vector and mRNA. RNA platform Our industry leading mRNA development and manufacturing solutions support rapid turnaround, advanced transcription capabilities and precision control over regulatory sequences design.

Company Details

Employees
17
Founded
-
Address
Isola Della Giudecca, 692b,italy
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Venice, Veneto
Looking for a particular Officinae Bio, Part Of Maravai Lifesciences employee's phone or email?

Officinae Bio, Part Of Maravai Lifesciences Questions

News

Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio - Business Wire

Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio Business Wire

Maravai LifeSciences Acquires DNA and RNA Business of Officinae Bio - Contract Pharma

Maravai LifeSciences Acquires DNA and RNA Business of Officinae Bio Contract Pharma

Maravai LifeSciences Holdings, Inc. (MRVI) Acquires Officinae Bio to Enhance AI-Driven mRNA Development - Yahoo Finance

Maravai LifeSciences Holdings, Inc. (MRVI) Acquires Officinae Bio to Enhance AI-Driven mRNA Development Yahoo Finance

How Is AI Shaping the Future of mRNA Therapeutics? - Technology Networks

How Is AI Shaping the Future of mRNA Therapeutics? Technology Networks

Maravai to Acquire Officinae Bio - San Diego Business Journal

Maravai to Acquire Officinae Bio San Diego Business Journal

Maravai LifeSciences to Acquire Officinae Bio’s DNA and RNA Business for Nucleic Acid Innovation - SynBioBeta

Maravai LifeSciences to Acquire Officinae Bio’s DNA and RNA Business for Nucleic Acid Innovation SynBioBeta

Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research - Business Wire

Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research Business Wire

‘A climate fund is way too generic,’ says Nucleus Capital - as it launches €40m fund focused on synthetic biology - Sifted

‘A climate fund is way too generic,’ says Nucleus Capital - as it launches €40m fund focused on synthetic biology Sifted

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant